Release Date: 07/11/18 09:32 Summary: Strategic Investor, Equity Placement & JV Partner for Caula Price Sensitive: Yes Download Document 600.79KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%